Page 37 - GTM-2-1
P. 37

Global Translational Medicine                                               Stem cells in aortic aneurysm



                                                               at the cellular and molecular levels. However, there are
                                                               several limitations  and  unresolved issues.  For example,
                                                               AAA is mostly induced by Ang II, which limits research
                                                               on inflammatory mechanisms. Research of TAA is most
                                                               focused on genetic models. In the occurrence, growth
                                                               and rupture  of AA,  more studies  have focused on the
                                                               developmental stage rather than defining the entire disease
                                                               process . Therefore, new models and more innovative
                                                                     [7]
                                                               approaches are needed to study AA.
                                                                 As for the role of stem cells in AA, the current research
                                                               may suggest that they play a crucial role in the occurrence
                                                               and development of AA. But more importantly, the
                                                               clinical treatment of AA by utilizing the differentiation
                                                               and proliferation ability of stem cells has a good prospect.
                                                               EPC will be mainly used for the prediction and prognostic
                                                               evaluation of AA, but at present, it is mainly used to
            Figure 3. Pharmacological and surgical treatment of AA.  study the mechanism of EPC for AA. A few randomized
            ACEI:  Angiotensin-converting  enzyme  inhibitor;  ARB:  Angiotensin   controlled clinical studies of MSCs in the treatment of
            receptor blocker; NSAID: Non-steroidal Ant-inflammatory Drugs;   AAA have been registered and implemented [109] . There is
            EVAR: Endovascular aneurysm repair; MMPI: Matrix metalloproteinase   no follow-up literature so far, but there is a growing number
            inhibitor.
                                                               of preclinical studies on the therapeutic potential of
            Recently, it has been practiced in a porcine model. In the   MSCs [61-64,85,88,89] , focusing on the in-depth study of stem cell
            aorta of animals treated with ADSC, the expression levels   therapy for AA [86,87,90,91] . Currently, the main direction is to
            of vascular endothelial factor, MMP1 tissue inhibitor, and   differentiate Muse cells into other cells for treatment [77,92,93] .
            MMP3 tissue inhibitor were increased, and aortic dilatation   Studies on ADSCs and MSCs are similar, mainly focusing
            was inhibited [95,96] . This new finding will facilitate further   on the inhibition of anti-inflammation in the development
            research on ADSC stem cell therapy for AA disease.  of AA [67-69,94-96] . The applications of iPSC-based technology
                                                               are extensive, including the establishment of disease
              The application of iPSC in TAA treatment is widely   models, regenerative cell therapy, drug discovery, and
            studied.  Cell  lines  of  human  induced  pluripotent  stem   predictive safety pharmacology [78-83,97,98]
            cells (hiPSC) have been generated for specific inherited
            vascular diseases such as Marfan syndrome [78,81] . There are   In general, many studies on applying stem cells in AA
            also recent studies in the treatment of AAA that collagen   treatment are based on animal models and are mainly
            scaffolds of induced pluripotent stem cell-derived smooth   preclinical mechanistic studies. Further research is urgently
            muscle progenitor cells (iPSC-SMPs) can be an effective   needed to overcome these limitations and promote the
            carrier for the delivery of VSMCs to the AAA site . iPSCs   research progress in the prediction and treatment of AA
                                                   [97]
            can also generate embryonic origin-specific VSMCs for   using stem cells.
            research use . iPSC technology for the treatment of AA
                      [98]
            has opportunities but also faces many challenges, such as   Acknowledgments
            the generation and quality of iPSCs, tumorigenicity risk,   None.
            and immune rejection . Therefore, the iPSC treatment
                              [99]
            technology is still in its infancy, and there are still numerous   Funding
            difficulties to  overcome in  practical clinical application.
            The above-mentioned applications of various stem cells in   This study was supported by the National Natural Science
            the treatment of AA are mainly based on research findings,   Foundation of China (81870186; 32271231).
            and thus, more extensive studies are still needed. In recent   Conflict of interest
            years, studies have mainly focused on mesenchymal stem
            cells from various sources, as shown in Table 2.   The authors declare they have no competing interests.
            5. Conclusion and outlook                          Author contributions

            AAA and TAA are severe and lethal diseases, and their   Conceptualization: Zhengyilei Wang, Baoqi Yu
            pathogenesis has been extensively studied and elucidated   Visualization: Yuzhe Yin, Yuge Zhang


            Volume 2 Issue 1 (2023)                         12                     https://doi.org/10.36922/gtm.v2i1.241
   32   33   34   35   36   37   38   39   40   41   42